141 related articles for article (PubMed ID: 4364937)
1. Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains.
Fiala M; Chow A; Guze LB
Antimicrob Agents Chemother; 1972 Apr; 1(4):354-7. PubMed ID: 4364937
[TBL] [Abstract][Full Text] [Related]
2. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
3. Variables influencing the in vitro susceptibilities of herpes simplex viruses to antiviral drugs.
Marks MI
Antimicrob Agents Chemother; 1974 Jul; 6(1):34-8. PubMed ID: 15828168
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the antiviral effects of 5-methoxymethyl-deoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside.
Babiuk LA; Meldrum B; Gupta VS; Rouse BT
Antimicrob Agents Chemother; 1975 Dec; 8(6):643-50. PubMed ID: 1239978
[TBL] [Abstract][Full Text] [Related]
5. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine.
Lerner AM; Bailey EJ
J Infect Dis; 1976 Oct; 134(4):400-4. PubMed ID: 185303
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus latency in cultured human cells following treatment with cytosine arabinoside.
O'Neill FJ; Goldberg RJ; Rapp F
J Gen Virol; 1972 Feb; 14(2):189-97. PubMed ID: 4334781
[No Abstract] [Full Text] [Related]
7. A rapid antiviral drug test by enzyme-linked immunoassay.
Landini MP; Baldassarri B
Diagn Immunol; 1983; 1(4):284-7. PubMed ID: 6094087
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.
Ayisi NK; Gupta VS; Meldrum JB; Taneja AK; Babiuk LA
Antimicrob Agents Chemother; 1980 Apr; 17(4):558-66. PubMed ID: 6249191
[TBL] [Abstract][Full Text] [Related]
9. Cytopathogenicity, drug susceptibility, and thymidine kinase activity of a retinovirulent herpes simplex virus type 2.
Langford MP; Colacino JM; Kaiwar R; Mahjoub SB; Ganley JP
J Med Virol; 1990 Aug; 31(4):301-5. PubMed ID: 2176674
[TBL] [Abstract][Full Text] [Related]
10. Simplified test for detecting the resistance of herpes simplex virus to acyclovir.
Agut H; Aubin JT; Ingrand D; Blanc S; Clayton AL; Chantler SM; Huraux JM
J Med Virol; 1990 Jul; 31(3):209-14. PubMed ID: 2167944
[TBL] [Abstract][Full Text] [Related]
11. Rapid assay of herpes simplex virus sensitivity to drugs.
Thornton JE; Smith KO
Acta Ophthalmol (Copenh); 1981 Apr; 59(2):259-70. PubMed ID: 6266194
[TBL] [Abstract][Full Text] [Related]
12. Syntheses of virus-induced thymidine kinase and viral DNA in herpes simplex type 1 virus-infected chick embryo fibroblasts.
Roubal J; Závada V; Zelená D; Hirsch I
Acta Virol; 1977 May; 21(3):177-83. PubMed ID: 18914
[TBL] [Abstract][Full Text] [Related]
13. Standardisation of a microplate in situ ELISA (MISE-test) for the susceptibility testing of herpes simplex virus to acyclovir.
Leahy BJ; Christiansen KJ; Shellam G
J Virol Methods; 1994 Jun; 48(1):93-108. PubMed ID: 7962265
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of recent clinical isolates of herpes simplex virus to 5-ethyl-2'-deoxyuridine: preferential inhibition of herpes simplex virus type 2.
Teh CZ; Sacks SL
Antimicrob Agents Chemother; 1983 May; 23(5):637-40. PubMed ID: 6307130
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of herpes simplex virus, vaccinia virus, and adenoviruses to deoxyribonucleic acid inhibitors and thiosemicarbazones in a plaque suppression test.
Herrmann EC
Appl Microbiol; 1968 Aug; 16(8):1151-5. PubMed ID: 4300089
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis.
Gephart JF; Lerner AM
Antimicrob Agents Chemother; 1981 Jan; 19(1):170-8. PubMed ID: 6166244
[TBL] [Abstract][Full Text] [Related]
17. [Various susceptibility to acriflavin in 2 strains of Herpesvirus hominis with different cytopathic effect].
Campione-Piccardo J; Rubén Barreto M
Rev Latinoam Microbiol; 1974; 16(4):217-26. PubMed ID: 4376255
[No Abstract] [Full Text] [Related]
18. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
[TBL] [Abstract][Full Text] [Related]
19. Effect of cytosine arabinoside and two of its analogues on herpes simplex virus type 1 in cell cultures.
Matsumoto S; Suganuma T; Ishida N
Tohoku J Exp Med; 1974 Dec; 114(4):393-4. PubMed ID: 4376281
[No Abstract] [Full Text] [Related]
20. A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents.
McLaren C; Ellis MN; Hunter GA
Antiviral Res; 1983 Nov; 3(4):223-34. PubMed ID: 6320716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
